Loading Complete
Edward James Tanner III

Edward James Tanner III, MD, MBA

Gynecologic Oncology

Gynecology

Accepting New Patients
Johns Hopkins Affiliations:
  • Johns Hopkins School of Medicine Faculty

Languages

  • English

Gender

Male

About

Professional Titles

  • Medical Director for Women's Health in the National Capital Region
  • Vice Chair for National Capital Region, Johns Hopkins Department of Gynecology and Obstetrics

Primary Academic Title

Professor (PAR) of Gynecology and Obstetrics

Background

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities.

 

Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time.

 

His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of ��Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute.

 

A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders.

Centers and Institutes

Videos

Recent News Articles and Media Coverage

Research Interests

Robotic and Minimally Invasive Surgery for Gynecologic Cancers, Sentinel Lymph Node Mapping of Endometrial Cancer, Surgical Management of Advanced Ovarian Cancer, Fertility Preservation for Cervical and Endometrial Cancer, Management of Uterine Sarcomas, Complex Benign Gynecologic Surgery

PubMed

http://www.ncbi.nlm.nih.gov/pubmed/?term=Tanner+EJ

Selected Publications

  • Tanner E, Black D, Zivanovic O, Kehoe S, Dao F, Konner J, Barakat R, Lichtman S, Levine D. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol. 2012; 124 (1): 59-62. PMID: 21982046.

  • Tanner E, Chi D, Eisenhauer E, Diaz-Montes T, Santillan A, Bristow R. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol. 2010; 117(2):336-40. PMID: 20153027.

  • Tanner E, Garg K, Leitao M, Soslow R, Hensley M. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol. 2012; 127 (1): 27-31. PMID: 22750260.

  • Tanner E, Leitao M, Garg K, Chi D, Sonoda Y, Gardner G, Barakat R, Jewell E. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol. 2011; 123 (3): 548-52. PMID: 21945551.

  • Tanner E, Long K, Feffer J, Leitao M, Abu-Rustum N, Barakat R, Chi D, Gardner G. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol. 2012; 128 (1): 28-33. PMID: 23017819.

  • Tanner E, Long K, Zhou Q, Brightwell R, Gardner G, Abu-Rustum N, Leitao M, Sonoda Y, Chi D. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol. 2012; 126 (1): 58-63. PMID: 22507533.

  • Tanner E, Sinno A, Stone R, Levinson K, Long K, Fader A. Factors Associated with Successful Bilateral Sentinel Lymph Node Mapping in Endometrial Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26095896.

  • Tanner E, Toussaint T, Leitao M, Hensley M, Soslow R, Gardner G, Jewell E. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol. 2013; 129 (1): 140-4. PMID: 23283300.

  • Tanner E, Zahurak M, Bristow R, Diaz-Montes T. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol. 2008; 111(2): 221-5. PMID: 18786718.

  • Barlin J, Long K, Tanner E, Gardner G, Leitao M, Levine D, Sonoda Y, Abu-Rustum N, Chi D. Optimal (≤1cm) but Visible Residual Disease: Is Extensive Debulking Warranted? Gynecol Oncol. 2013; 130 (2): 284-8. PMID: 23672929.

  • Cholakian D, Hacker K, Fader A, Gehrig P, Tanner E. Effect of Oral Versus Intrauterine Progestins on Weight in Women Undergoing Fertility Preserving Therapy for Complex Atypical Hyperplasia or Endometrial Cancer. Gynecol Oncol 2015; [epub ahead of print]. 

  • Cripe J, Tseng J, Eskander R, Fader A, Tanner E, Bristow R. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality. Ann Surg Oncol. 2014; 22(2): 655-61. PMID: 25155402.

  • Fader A, Java J, Krivak T, Bristow R, Tergas A, Bookman M, Armstrong D, Tanner E, Gershenson D. The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2014; 132(3):560-5. PMID: 24333362.

  • Fader A, Weise R, Sinno A, Tanner E, Borah B, Moriarty J, Bristow R, Makary M, Pronovost P, Hutfless S, Dowdy S. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Gynecol Oncol 2015; [epub ahead of print]. PMID: 26646127.

  • Hyman D, Long K, Tanner E, Grisham R, Arnold A, Bhatia J, Spriggs D, Soslow R, Kauff N, Levine D. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol. 2012; 126 (2): 224-8. PMID: 22579790.

  • Kushnir C, Angarita A, Havrilesky L, Thompson S, Spahlinger D, Sinno A, Tanner E, Secord A, Roche K, Stone R, Fader A. Selective Cardiac Surveillance in Patients with Gynecologic Cancer Undergoing Treatment with Pegylated Liposomal Doxorubicin (PLD). Gynecol Oncol. 2015; 137(3): 503-7. PMID: 25735254.

  • Long K, Tanner E, Frey M, Leitao M, Levine D, Gardner G, Sonoda Y, Abu-Rustum N, Barakat R, Chi D. Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity. Gynecol Oncol. 2013; 131(3): 525-30. PMID: 24016410.

  • Pant A, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli R, Holloway R, Bristow R. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother. 2010; 22(4): 270-4. PMID: 20685633.

  • Ricci S, Giuntoli R, Eisenhauer E, Lopez M, Krill L, Tanner E, Gehrig P, Havrilesky L, Secord A, Levinson K, Frasure H, Celano P, Fader A. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecol Oncol. 2013; 131 (3): 629-33. PMID: 24016408.

  • Sandadi S, Tanner E, Khoury-Collado F, Kostolias A, Makker V, Chi D, Sonoda Y, Alektiar K, Barakat R, Abu-Rustum N. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Oncol. 2013; 23 (3): 553-8. PMID: 23392402.

  • Scheib S, Tanner E, Green I, Fader A. Laparoscopy in the Morbidly Obese: Physiologic Considerations and Surgical Techniques to Optimize Success. J Minim Invasive Gynecol. 2013; 21 (2): 182-95.  PMID: 24100146.

  • Shih K, Qin L-X, Tanner E, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat R, Levine D. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol. 2011; 121 (3): 444-50. PMID: 21354599.

  • Sinno A, Tanner E. Robotic Laparoendoscopic Single Site Radical Hysterectomy with Sentinel Lymph Node mapping and Pelvic Lymphadenectomy for Cervical Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26307401.

  • Sinno A, Fader A, Tanner E. Single Site Robotic Sentinel Lymph Node Biopsy and Hysterectomy in Endometrial Cancer. Gynecol Oncol. 2015; 137(1): 190. PMID: 25684218

  • Sinno A, Fader A, Long K, Giuntoli R, Tanner E. A Comparison of Colorimetric versus Fluorometric Sentinel Lymph Node Mapping During Robotic Surgery for Endometrial Cancer. Gynecol Oncol. 2014; 134 (2): 281-6. PMID: 24882555.

  • Suidan R, St. Clair C, Lee S, Barlin J, Long Roche K, Tanner E, Sonoda Y, Barakat R, Zivanovic O, Chi D. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014; 134 (3): 468-72. PMID: 25042672.

  • Suidan R, Zhou Q, Iasonos A, O'Cearbhaill R, Chi D, Long Roche K, Tanner E, Denesopolis J, Barakat R, Zivanovic O. Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2015; 25(4): 599-606. PMID: 2566443

Honors

  • Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/13
  • Virginia K. Pearce Award for Best Poster, Society of Memorial Gynecologic Oncologists Annual Meeting, 1/1/09
  • Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/08
  • Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/06

Lectures & Presentations

  • Fluorometric Imaging for Endometrial Cancer, Invited Lecture, 2nd Fengxian International Forum of Medical Science and Technology, Shanghai, China, 8/30/14
  • Introduction of a Sentinel Lymph Node Mapping Program, Endometrial Cancer at Johns Hopkins Hospital, Boston, MA, 12/5/13
  • Practical Paradigms for Critical Clinical Challenges in Gynecologic Oncology, Classification and Current Treatment Strategies for Uterine Sarcomas, SGO 2012 State of the Art Conference, Washington, DC, 11/3/12
  • Screening for Gynecologic Cancers, Sentara Northern Virginia Medical Center, Woodbridge, 1/3/13
  • Screening for Gynecologic Cancers, Grand Round Lectures, Sentara Northern Virginia Medical Center, Woodbridge, VA, 4/3/13
  • Screening for Ovarian Cancer, Greater Baltimore Medical Center, Baltimore, 1/19/12
  • Screening for Ovarian Cancer, Sibley Memorial Hospital, Washington, 1/4/13
  • Screening for Ovarian Cancer, Georgetown/Washington Hospital Center, Washington, 1/24/13
  • Screening for Ovarian Cancer, Grand Round Lectures, Greater Baltimore Medical Center, Baltimore, MD, 10/19/12
  • Screening for Ovarian Cancer, Grand Round Lectures, Sibley Memorial Hospital, Washington, DC, 3/4/13
  • Screening for Ovarian Cancer, Grand Round Lectures, Georgetown/Washington Hospital Center, Washington, DC, 10/24/13
  • Sentinel Lymph Node Mapping for Endometrial Cancer, Invited Speaker, Grand Rounds, University of Maryland Department of OB/GYN, Baltimore, MD, 2/13/15
  • Single Port Robotic Surgery, Invited Speaker, Surgical Innovations Course, Updates and Innovations in Gynecologic Surgery Course, Johns Hopkins Hospital, Baltimore, MD, 5/29/15
  • Techniques, Advantages, and Drawbacks of Single-port Surgery, Invited Lecture, Surgical Innovations Course, Minimally Invasive Therapy Single Incision Laparoscopic Surgery Workshop, Asia-Pacific Association for Gynecologic Endoscopy, Shanghai, China, 11/3/15
  • The Skinny on the Mini: Minilaparoscopy, LESS, Robotic Single-Site and the Next Frontier in Alternative Access, Conventional Laparoscopic Access Techniques: A Review and Critical Appraisal, AAGL Annual Meeting, Washington, DC, 11/11/13

Memberships

  • American Association of Gynecologic Laparoscopy
  • American College of Obstetrics and Gynecology
  • Mid-Atlantic Gynecologic Oncology Society
  • Society of Gynecologic Oncology
  • Society of Memorial Gynecologic Oncologists

Locations

  1. Sibley Memorial Hospital
    • 5275 Loughboro Road Northwest, Building D, Washington, DC 20016
    • Johns Hopkins Health Care & Surgery Center — Bethesda
      • 10215 Fernwood Road, Suite 630, Bethesda, MD 20817

      Expertise

      Education

      Johns Hopkins Carey Business School

      Graduate School, Business, MBA, 2021

      Memorial Sloan Kettering Cancer Center

      Fellowship, Gynecologic Oncology, 2012

      Johns Hopkins University School of Medicine

      Residency, Obstetrics and Gynecology, 2008

      University of Alabama at Birmingham

      Medical Education, MD, 2004

      Board Certifications

      Gynecologic Oncology

      American Board of Obstetrics and Gynecology, 2015

      Obstetrics and Gynecology

      American Board of Obstetrics and Gynecology, 2013